Risk Partners Life Sciences Roundtable 2024, thank you very much! Already for the 26.06.2025 >

Growth capital for biotechnology
and life sciences - Finance Day 2024

A few days ago, Jutta and Florian from our team attended Finance Day 2024 at the analytica trade fair in Munich. The event once again offered exciting expert panels on current financing and capital market issues for life sciences companies. As the panels focused on three of our key consulting areas, namely life sciences, venture capital and IPOs, attending was of course a must for us as a specialist insurance broker. Our team was also delighted to meet many of our partners and clients again and talk to them about the importance of risk management and insurance solutions.

The startup panel was also interesting and once again demonstrated the innovative spirit of the industry. Ten companies were selected for this, nine of which were even presented in person by a founder. Take a look at the companies and if you are interested in the product or an investment, please contact the ladies or gentlemen directly. We are keeping our fingers crossed! 

  1. Better Basics Laborbedarf GmbH(Mario Schneider)
  2. Intu Diagnostics GmbH(Dr. Dirk Kuhlmeier )
  3. Pacifico Biolabs GmbH(Washington Logroño)
  4. Dr. Purus Enorm Smart Technik GmbH(Dr. Bo Liu)
  5. goodBot GmbH(Dr. Julius Wiener)
  6. hema.to GmbH(Dr. Karsten Miermanns)
  7. IRUBIS GmbH(Anja Müller)
  8. Opto Biolabs GmbH(Dr. Kathrin Brenker)
  9. Safia Technologies GmbH(Dr. Timm Schwaar)
  10. CamSens GmbH(Enrika Barreto

In addition, the challenges of the financing environment were again discussed from various perspectives. The desire for a European capital market that would combine the strengths of Frankfurt, Euronext and NASDAQ Europe was articulated fairly unanimously. From our point of view as a specialist insurance broker, this is also desirable, although the standardization of the liability framework would certainly become even more challenging, so that different solutions for each stock exchange would no longer be necessary, as is currently the case.  

In conclusion, we are delighted to have been part of these events and will be back at the next one in Leipzig. Thanks also to the team of Plattform Life Sciences and Going Public Media AG for the great organization and the successful framework of the event! We had a lot of fun. 

Also read our other blog posts

Management

Research breakdown at Stockholm's Karolinska Institute: A cooling failure destroys cell cultures from decades of research

Research mishap at Stockholm's Karolinska Institute: A cooling failure destroys cell cultures from decades of research - can you insure against it? An incident that threatens your very existence, but which we would like to shed some light on from the perspective of an insurance broker specializing in life sciences. What happened? A cooling system at the Karolinska Institute in Stockholm, Sweden's most important medical research center, failed for five days. Biological material that had been collected over 30 years and, according to the institute, was unique in the world, was destroyed as a result. The material was stored in deep-freeze tanks in which the temperature

Read more "
Management

OLG Schleswig – Statute of Limitations for Liability Claims in the Case of Direct Claims in D&O Insurance

OLG Schleswig: Statute of limitations for liability claims in the case of direct claims in D&O insurance. There is a new, exciting verdict from the world of D&O insurance. Recently, we reported on the decision of the Higher Regional Court of Cologne in the context of the direct lawsuit. Now the Higher Regional Court of Schleswig has also made a groundbreaking decision. What was it about? The focus was on the question of the statute of limitations. However, it must be taken into account that the question of the statute of limitations in the event of a D&O claim is not trivial. On the one hand, there is the original claim for damages (statutory D&O liability

Read more "
Being Public

Public prosecutor's office investigates: Suspicion of deception in short-time work (Sono Motors)

No startup bonus for criminal and administrative offenses. The incident and possible insurance cover. As exclusively researched by Hannah Schwär and her team at Capital Magazin, the founders of Sono Motors are now also facing problems with the public prosecutor's office. According to Capital Magazin, subsidy fraud in the context of short-time work and the programs surrounding the corona crisis is in the offing. The company, which is listed on the NASDAQ via De-SPAC, has already filed a report with the SEC. While the loss amount of EUR 40,000 is still being

Read more "
Your question has not been answered?
We will be happy to advise you in a free initial consultation.

Receive the Life Sciences Insurance Protection Guide free of charge!

Everything you need to know to optimally protect you and your life sciences / biotech company.